Oncolytics Biotech (ONCY) Price to FCF (2009 - 2025)

Oncolytics Biotech (ONCY) has reported Price to FCF for 17 consecutive years, with 28.22 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Price to FCF fell 53.34% year-over-year to 28.22 in Q3 2025; TTM through Sep 2025 was 7.21, a 104.76% decrease from a year earlier, with the FY2025 full-year figure at 4.67, down 25.23% from the prior year.
• Price to FCF was 28.22 for Q3 2025 at Oncolytics Biotech, down from 19.0 in the prior quarter.
• Over five years, Price to FCF peaked at 9.72 in Q1 2025 and troughed at 39.98 in Q1 2021.
• A 5-year average of 20.66 and a median of 19.0 in 2025 frame the typical range for Price to FCF.
• Across the five-year window, Price to FCF slumped 321.71% in 2021 and soared 55.67% in 2022, its largest moves.
• Over 5 years, Price to FCF stood at 15.41 in 2021, then slumped by 48.28% to 22.84 in 2022, then grew by 2.18% to 22.35 in 2023, then surged by 41.94% to 12.97 in 2024, then slumped by 117.48% to 28.22 in 2025.
• The last three Price to FCF figures came in at 28.22 (Q3 2025), 19.0 (Q2 2025), and 9.72 (Q1 2025), per Business Quant data.